Exagen (XGN)
(Delayed Data from NSDQ)
$1.41 USD
0.00 (0.15%)
Updated Apr 26, 2024 03:50 PM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
Income Statements
Fiscal Year end for Exagen Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 53 | 46 | 48 | 42 | 40 |
Cost Of Goods | 23 | 24 | 21 | 17 | 19 |
Gross Profit | 29 | 21 | 28 | 25 | 22 |
Selling & Adminstrative & Depr. & Amort Expenses | 52 | 67 | 52 | 41 | 31 |
Income After Depreciation & Amortization | -23 | -46 | -24 | -15 | -9 |
Non-Operating Income | 2 | 1 | 0 | 1 | 1 |
Interest Expense | 2 | 2 | 3 | 3 | 3 |
Pretax Income | -24 | -48 | -27 | -17 | -12 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -24 | -47 | -27 | -17 | -12 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -24 | -47 | -27 | -17 | -12 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -21 | -39 | -23 | -14 | -8 |
Depreciation & Amortization (Cash Flow) | 2 | 7 | 1 | 1 | 1 |
Income After Depreciation & Amortization | -23 | -46 | -24 | -15 | -9 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 17.68 | 17.08 | 15.97 | 12.63 | 3.58 |
Diluted EPS Before Non-Recurring Items | -1.34 | -2.52 | -1.68 | -1.32 | -8.46 |
Diluted Net EPS (GAAP) | -1.34 | -2.77 | -1.68 | -1.32 | -8.46 |
Fiscal Year end for Exagen Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 13.77 | 13.42 | 14.14 | 11.23 |
Cost Of Goods | NA | 5.62 | 5.71 | 5.84 | 5.93 |
Gross Profit | NA | 8.15 | 7.71 | 8.30 | 5.30 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 13.30 | 12.78 | 13.21 | 13.01 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -5.15 | -5.07 | -4.91 | -7.71 |
Non-Operating Income | NA | 0.86 | 0.21 | 0.48 | 0.66 |
Interest Expense | NA | 0.57 | 0.56 | 0.57 | 0.64 |
Pretax Income | NA | -5.54 | -5.42 | -5.01 | -7.69 |
Income Taxes | NA | 0.03 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -5.57 | -5.42 | -5.01 | -7.69 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -5.57 | -5.42 | -5.01 | -7.69 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 17.84 | 17.69 | 17.66 | 17.53 |
Diluted EPS Before Non-Recurring Items | NA | -0.31 | -0.31 | -0.28 | -0.44 |
Diluted Net EPS (GAAP) | NA | -0.31 | -0.31 | -0.28 | -0.44 |